- Home
- BVC vs LYEL Comparison
BVC vs LYEL Comparison
Compare BVC & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$21.25
Company Overview
Basic Information| Metric | BVC | LYEL |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 490.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BVC | LYEL |
|---|---|---|
| Price | $7.89 | $21.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $27.25 |
| AVG Volume (30 Days) | 1.6K | ★ 96.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $61,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.99 | $0.39 |
| 52 Week High | $15.00 | $45.00 |
Technical Indicators
Market Signals| Indicator | BVC | LYEL |
|---|---|---|
| Relative Strength Index (RSI) | 55.19 | 40.46 |
| Support Level | $6.20 | $15.82 |
| Resistance Level | $8.27 | $27.30 |
| Average True Range (ATR) | 0.33 | 1.85 |
| MACD | 0.09 | 0.06 |
| Stochastic Oscillator | 78.61 | 3.97 |
Price Performance
Historical Comparison BVC
LYEL
About BVC BitVentures Limited American Depositary Shares
BitVentures Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. The Company is developing technology businesses in verticals including e-commerce, digital assets, consumer healthcare, and other areas of consumer.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.